Can low omega-3 intake and FADS, PEMT, and LTC4S variants shift membrane lipids toward inflammatory signaling?

Cellular membrane phospholipid composition is highly sensitive to the balance of dietary omega-3 fatty acids and arachidonic acid (AA). When dietary omega-3s are low, AA dominates the lipid bilayer, altering downstream cellular signaling.

Genetic and membrane dynamics

• PUFA desaturation constraints: FADS1 and FADS2 gene variants regulate the rate-limiting desaturation steps of polyunsaturated fatty acid (PUFA) synthesis, directly controlling endogenous EPA and DHA levels.
• Phospholipid remodeling: PEMT variants, such as rs7946, restrict the synthesis and remodeling of DHA-rich phosphatidylcholine (PC) species, further depleting membrane omega-3 pools and promoting AA retention in cell membranes.

Downstream signaling cascades

• Pro-inflammatory signaling bias: Under conditions of low omega-3 and dominant membrane AA, cellular activation triggers the selective release of AA via phospholipases, feeding downstream cyclooxygenase (COX) and lipoxygenase (LOX) pathways.
• Leukotriene production: Genetic variants in LTC4S (such as rs730012) alter transcription to accelerate the enzymatic conversion of AA-derived intermediates, driving the synthesis of potent, pro-inflammatory cysteinyl leukotrienes.
• Impaired inflammatory resolution: The depletion of membrane EPA and DHA deprives the cell of the essential precursors needed to synthesize specialized pro-resolving mediators (SPMs), such as resolvins and protectins, preventing the active resolution of inflammation.

Bottom line

• Functional variants in FADS, PEMT, and LTC4S interact with dietary fatty acid availability to alter membrane composition, shifting the cellular state toward arachidonic acid-derived pro-inflammatory leukotriene signaling and away from active, omega-3-driven resolution pathways.